We are live on
!
Find out more
Adaptive Biotechnologies
ADPT
ADPT
283 hedge funds and large institutions have $2.44B invested in Adaptive Biotechnologies in 2025 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 101 increasing their positions, 91 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
79% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $825K
37% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 38
12% more capital invested
Capital invested by funds: $2.18B → $2.44B (+$267M)
11% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 91
4% more funds holding
Funds holding: 271 → 283 (+12)
2.99% more ownership
Funds ownership: 95.5% → 98.49% (+3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
283
Holders Change
+12
Holders Change %
+4.43%
% of All Funds
3.44%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
52
Increased
101
Reduced
91
Closed
38
Calls
$1.48M
Puts
$825K
Net Calls
+$653K
Net Calls Change
+$366K
Top Buyers
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$66.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$53.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$36.2M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$30.3M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.2M |
